These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11422931)

  • 1. Safety of intravenous iron during infections.
    Fishbane S
    Semin Dial; 2001; 14(3):228. PubMed ID: 11422931
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous iron and hypersensitivity.
    Prescrire Int; 2007 Apr; 16(88):71-2. PubMed ID: 17465035
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of intravenous iron in the current clinical practice.
    Beneitez Pastor D
    Med Clin (Barc); 2018 Mar; 150(5):188-190. PubMed ID: 28662885
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous iron therapy in renal failure: friend and foe?
    Afzali B; Goldsmith DJ
    J Nephrol; 2004; 17(4):487-95. PubMed ID: 15372409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral iron therapy: indications and safety.
    Marwaha RK; Trehan A
    Indian Pediatr; 1997 Mar; 34(3):261-2. PubMed ID: 9282501
    [No Abstract]   [Full Text] [Related]  

  • 6. [The behavior of intravenously administered iron in the organism].
    LINTZEL W
    Arztl Forsch; 1953 Mar; 7(3):I/134-6. PubMed ID: 13065190
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron in hematology: Danger with IV iron: Real or perceived?
    Auerbach M
    Am J Hematol; 2014 Jun; 89(6):664. PubMed ID: 24639085
    [No Abstract]   [Full Text] [Related]  

  • 8. New intravenous iron replacement therapies.
    Auerbach M
    Clin Adv Hematol Oncol; 2010 Oct; 8(10):688-9. PubMed ID: 21317865
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous administration of iron gluconate during haemodialysis.
    Calvar C; Mata D; Alonso C; Ramos B; Lopez de Novales E
    Nephrol Dial Transplant; 1997 Mar; 12(3):574-5. PubMed ID: 9075144
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous iron therapy in end-stage renal disease.
    Brewster UC
    Semin Dial; 2006; 19(4):285-90. PubMed ID: 16893405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety aspects of parenteral iron in patients with end-stage renal disease.
    Sunder-Plassmann G; Hörl WH
    Drug Saf; 1997 Oct; 17(4):241-50. PubMed ID: 9352960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Balancing Benefits and Safety with Intravenous Iron Treatment.
    Alan Brookhart M; Li X; Kshirsagar AV
    Semin Dial; 2017 Jan; 30(1):25-27. PubMed ID: 27766683
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
    Susantitaphong P; Alqahtani F; Jaber BL
    Am J Nephrol; 2014; 39(2):130-41. PubMed ID: 24513913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
    Potthoff SA; Münch HG
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1312-7. PubMed ID: 23737117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia of pregnancy treated with intravenous iron. 1951.
    Scott JM; Govan AD
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123 Suppl 2():S29-32. PubMed ID: 16360538
    [No Abstract]   [Full Text] [Related]  

  • 16. What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Emerging Evidence on the Safety of Intravenous Iron in Chronic Kidney Disease.
    Agarwal R
    Semin Dial; 2017 Jan; 30(1):22-25. PubMed ID: 27678472
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous iron gluconate administration increases circulating PAPP-A in hemodialysis patients.
    Hodkova M; Kalousova M; Dusilova-Sulkova S; Malbohan IM; Zima T
    Ren Fail; 2005; 27(6):707-11. PubMed ID: 16350822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron as adjuvant therapy: a two-edged sword?
    Cavill I
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii24-8. PubMed ID: 14607997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the evaluation and management of iron deficiency anemia in inflammatory bowel disease.
    Aksan A; Farrag K; Stein J
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):95-97. PubMed ID: 30791779
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iron deficiency without anemia: where are we in 2012?].
    Favrat B; Waldvogel Abramowski S; Vaucher P; Cornuz J; Tissot JD
    Rev Med Suisse; 2012 Nov; 8(364):2277-8, 2280-1. PubMed ID: 23240240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.